Close
  Indian J Med Microbiol
 

Figure 1: Possible mechanism for angiogenic and antiapoptotic properties of erythropoietin. EPO: Erythropoietin, EPOR: Erythropoietin receptor, PI3K: Phosphoinositide 3-kinase; AKT: Protein kinase; CASP: Caspase, GSK: Glycogen synthase kinase-3, AP-1: Activator protein-1, BCL-2: B-cell lymphoma 2. This figure is reprinted from a published paper by Gao D, Ning N, Niu X, Dang Y, Dong X, Wei J, et al. Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials. Am Heart J 2012;164:715-27.e1. With permission granted from ELSEVIER publisher

Figure 1: Possible mechanism for angiogenic and antiapoptotic properties of erythropoietin. EPO: Erythropoietin, EPOR: Erythropoietin receptor, PI3K: Phosphoinositide 3-kinase; AKT: Protein kinase; CASP: Caspase, GSK: Glycogen synthase kinase-3, AP-1: Activator protein-1, BCL-2: B-cell lymphoma 2. This figure is reprinted from a published paper by Gao D, Ning N, Niu X, Dang Y, Dong X, Wei J, <i>et al</i>. Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials. Am Heart J 2012;164:715-27.e1. With permission granted from ELSEVIER publisher